LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
- PMID: 33431817
- PMCID: PMC7801696
- DOI: 10.1038/s41419-020-03302-2
LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
Abstract
Radioresistance is the main obstacle in the clinical management of nasopharyngeal carcinoma (NPC). linc00312 is deregulated in a number of human cancers, including NPC. However, the detailed functions and underlying mechanisms of linc00312 in regulating radiosensitivity of NPC remains unknown. In this study, cox regression analysis was used to assess the association between linc00312 and NPC patients' survival after radiotherapy. Our results reveal that linc00312 is significantly down-regulated in NPC tissues and patients with higher expression of linc00312 are significantly associated with longer overall survival and better short-term radiotherapy efficacy. Overexpression of linc00312 could increase the sensitivity of NPC cells to ionizing radiation, as indicated by clonogenic survival assay, comet assay, and flow cytometry. Mechanistically, RNA pull down and RNA immunoprecipitation were performed to investigate the binding proteins of linc00312. linc00312 directly binds to DNA-PKcs, hinders the recruitment of DNA-PKcs to Ku80, and inhibits phosphorylation of AKT-DNA-PKcs axis, therefore inhibiting the DNA damage signal sensation and transduction in the NHEJ repair pathway. In addition, linc00312 impairs DNA repair and cell cycle control by suppressing MRN-ATM-CHK2 signal and ATR-CHK1 signal. In summary, we identified DNA-PKcs as the binding protein of linc00312 and revealed a novel mechanism of linc00312 in the DNA damage response, providing evidence for a potential therapeutic strategy in NPC.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.Biomed Pharmacother. 2020 Mar;123:109748. doi: 10.1016/j.biopha.2019.109748. Epub 2019 Dec 20. Biomed Pharmacother. 2020. PMID: 31869663
-
Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.J Mol Histol. 2013 Oct;44(5):545-54. doi: 10.1007/s10735-013-9503-x. Epub 2013 Mar 26. J Mol Histol. 2013. PMID: 23529758
-
LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.Cell Death Dis. 2021 May 7;12(5):454. doi: 10.1038/s41419-021-03728-2. Cell Death Dis. 2021. PMID: 33963177 Free PMC article.
-
Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.Curr Mol Pharmacol. 2020;13(3):192-205. doi: 10.2174/1874467213666191227104646. Curr Mol Pharmacol. 2020. PMID: 31880267 Review.
-
The exciting encounter between lncRNAs and radiosensitivity in IR-induced DNA damage events.Mol Biol Rep. 2023 Feb;50(2):1829-1843. doi: 10.1007/s11033-022-07966-1. Epub 2022 Dec 12. Mol Biol Rep. 2023. PMID: 36507968 Review.
Cited by
-
Radioresistance and brain metastases: a review of the literature and applied perspective.Front Oncol. 2024 Oct 30;14:1477448. doi: 10.3389/fonc.2024.1477448. eCollection 2024. Front Oncol. 2024. PMID: 39540151 Free PMC article. Review.
-
LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis.Sci Rep. 2022 Nov 2;12(1):18494. doi: 10.1038/s41598-022-21785-1. Sci Rep. 2022. PMID: 36323697 Free PMC article.
-
Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications.Mol Cell Biochem. 2021 Sep;476(9):3537-3550. doi: 10.1007/s11010-021-04176-4. Epub 2021 May 17. Mol Cell Biochem. 2021. PMID: 33999333 Review.
-
TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance.Int J Biol Sci. 2024 Jan 1;20(1):182-199. doi: 10.7150/ijbs.87180. eCollection 2024. Int J Biol Sci. 2024. PMID: 38164179 Free PMC article.
-
Linc01513 inhibits the malignant potential of Nasopharyngeal carcinoma by binding to PTBP1.J Cancer. 2021 Oct 28;12(24):7380-7389. doi: 10.7150/jca.62112. eCollection 2021. J Cancer. 2021. PMID: 35003358 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous